Imunon, Inc. — Director's Dealing 2025

Aug 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2025-08-04

Reporting Person: Anwer Khursheed (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-04	Stock Option (Right to Buy)	$9.20	A	1667	Acquired	2035-08-04	Common Stock (1667)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.